Drug recall · January 25, 2023
Tobramycin Ophthalmic Solution recall
Why: CGMP Deviations:
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tobramycin Ophthalmic Solution, USP, 0.3%, 5 mL per dropper bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-290-10
- Lots / codes
Lot: 1C56A, EXP 2/28/2023; 1J50A, EXP 8/31/2023; 1K61A, EXP 9/30/2023 ; 1M27A, EXP 11/30/2023;
- Quantity
- 2,095,068 bottles
- Company
- Akorn, Inc., Gurnee, IL
- Distribution
- Nationwide in the USA
- Initiated
- October 13, 2022 · Voluntary: Firm initiated
- Classified
- January 13, 2023
- Reported
- January 25, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tobramycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.